Check out our latest review, led by Austin Chiang @wtchiang2013 "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy" https://t.co/2qPfAr6N6w https://t.co/KvvPFpzMBu https://t.co/RXpMnN2A83
Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2021 – Nov 2023Where it's discussed
-
X / Twitter6 posts
-
YouTube3 videos
AI synopsis
What people are saying
The overall discussion shows positive acknowledgment of the review's contributions, with examples such as praise for its thoroughness and discussion of promising yet challenging avenues in immuno-oncology. The tone and choice of words like 'great work' and 'promises' suggest optimism about the article's importance for advancing personalized cancer therapies.
Most discussions express support and recognize the importance of the research, highlighting its potential in advancing immunotherapy.
The posts indicate a moderate level of interest, as they reference the review work and its relevance to the field, but do not delve into detailed critique or alternative views.
The mentions of specific researchers and concepts like glycoimmunotherapy suggest a genuine engagement with the subject, although the interactions are mostly brief and supportive.
The frequent use of phrases like 'great promises,' 'challenges,' and recognition of the review's significance reflect a belief that this work could have a meaningful impact on future cancer treatments.
Abstract in brief
- This text discusses how systems glycobiology is advancing cancer immunotherapy by understanding the role of abnormal glycosylation in tumor-immune interactions, which could lead to new drug targets and biomarkers.
- It highlights recent progress in immunotherapy, including Nobel-winning research on immune checkpoints like CTLA4 and PD1, and emphasizes the need for more personalized treatments across different cancer types.
- The article also explores how emerging technologies in systems glycobiology can provide deeper insights into immune responses, helping design more effective glycoimmunotherapies and improve clinical outcomes.]
Top posts
Most liked on X and BlueskyOur latest review "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy" discusses the great promises and challenges in the immuno-oncology field. Great work with @hmbaghdassarian and @Nathan_E_Lewis. https://t.co/CsLF63SvRv
RT @wtchiang2013: Our latest review "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunoth…
Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy https://t.co/3sHpej6rV8 https://t.co/Y59anhxhOE
RT @Nathan_E_Lewis: Check out our latest review, led by Austin Chiang @wtchiang2013 "Systems glycobiology for discovering drug targets, b…
Systems glycobiology for discovering drug targets, biomarkers, and rational designs for #glycoimmunotherapy
All mentions
Advances in Glycosylation-Based Cancer Immunotherapy Strategies
This video explores how systems glycobiology is advancing cancer immunotherapy by analyzing abnormal glycosylation in tumor-immune interactions, leading to potential new drug targets, biomarkers, and more effective…
Advancing Cancer Immunotherapy Through Systems Glycobiology
This video explores how systems glycobiology advances cancer immunotherapy by analyzing abnormal glycosylation's role in tumor-immune interactions, aiding in the discovery of drug targets and biomarkers for personalized…
miRNA Regulation of Glycan Precursor Synthesis in Cancer Cells
This video explores how microRNA influences glycosylation and glycan synthesis in tumor cells, highlighting its potential impact on cancer immunotherapy and biomarker discovery.
Systems glycobiology for discovering drug targets, biomarkers, and rational designs for #glycoimmunotherapy
RT @Nathan_E_Lewis: Check out our latest review, led by Austin Chiang @wtchiang2013 "Systems glycobiology for discovering drug targets, b…
Check out our latest review, led by Austin Chiang @wtchiang2013 "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy" https://t.co/2qPfAr6N6w https://t.co/KvvPFpzMBu https://t.co/RXpMnN2A83
RT @wtchiang2013: Our latest review "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunoth…
Our latest review "Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy" discusses the great promises and challenges in the immuno-oncology field. Great work with @hmbaghdassarian and @Nathan_E_Lewis. https://t.co/CsLF63SvRv
Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy https://t.co/3sHpej6rV8 https://t.co/Y59anhxhOE